This document discusses the evidence for buprenorphine treatment of opioid dependent adolescents and young adults. It provides treatment recommendations, and highlights special issues that should be considered when treating this special population.
This document discusses the logistics of successful buprenorphine induction, offering insight into clinical questions that should be addressed, the goal of induction, general principles, and recommendations based on low and high levels of evidence. Recommendations are included for both in-office and at-home inductions.
A member of The Clinical Tools, Inc (CTI) Addiction Training Group: SBIRT Training | Opioid Risk Reduction | Buprenorphine Training
Clinical Tools, Inc. is accredited by the ACCME to provide continuing medical education for physicians. Interactive training is delivered by the FAOS DLearning System and requires IE 7/ higher, Firefox, Chrome or Safari.
Unless otherwise noted, individuals pictured are models and are used for illustrative purposes only.